AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$621M |
| 2 |
Visa
V
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$542M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$525M |
| 5 |
Amazon
AMZN
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$693M |
| 2 |
Texas Instruments
TXN
|
+$477M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$235M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 14.87% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Financials | 12.61% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
1826
Apollo Commercial Real Estate
ARI
$867M
| $3.4M | ﹤0.01% |
228,947
-8,480
| -4% | -$130K |
|
|
IRBT
1827
DELISTED
iRobot
IRBT
| $3.39M | ﹤0.01% |
43,233
-6,040
| -12% | -$515K |
|
1828
Forward Air
FWRD
$454M
| $3.39M | ﹤0.01% |
40,834
-1,330
| -3% | -$116K |
|
1829
Agios Pharmaceuticals
AGIO
$2.09B
| $3.39M | ﹤0.01% |
73,360
-600
| -0.8% | -$29K |
|
1830
Editas Medicine
EDIT
$396M
| $3.38M | ﹤0.01% |
82,304
| – | – |
|
1831
Esquire Financial Holdings
ESQ
$1.11B
| $3.38M | ﹤0.01% |
117,926
+29,734
| +34% | +$758K |
|
1832
Atea Pharmaceuticals
AVIR
$357M
| $3.38M | ﹤0.01% |
96,288
+6,488
| +7% | +$180K |
|
1833
J&J Snack Foods
JJSF
$1.52B
| $3.37M | ﹤0.01% |
22,080
-5,505
| -20% | -$896K |
|
1834
Federal Signal
FSS
$6.86B
| $3.37M | ﹤0.01% |
87,274
-3,860
| -4% | -$152K |
|
|
MDP
1835
DELISTED
Meredith Corporation
MDP
| $3.37M | ﹤0.01% |
60,448
-1,920
| -3% | -$83.8K |
|
1836
BioCryst Pharmaceuticals
BCRX
$2.43B
| $3.36M | ﹤0.01% |
233,920
-3,400
| -1% | -$53.6K |
|
1837
Sportradar
SRAD
$4.39B
| $3.36M | ﹤0.01% |
+148,283
| New | +$3.79M |
|
|
MLVF
1838
DELISTED
Malvern Bancorp, Inc.
MLVF
| $3.35M | ﹤0.01% |
197,347
+3,757
| +2% | +$68K |
|
1839
Laureate Education
LAUR
$5.39B
| $3.35M | ﹤0.01% |
197,141
+63,608
| +48% | +$1,000K |
|
|
ITCI
1840
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.33M | ﹤0.01% |
89,310
-1,300
| -1% | -$45.2K |
|
1841
Axalta
AXTA
$7.57B
| $3.33M | ﹤0.01% |
113,928
+184
| +0.2% | +$5.5K |
|
|
SPWR
1842
DELISTED
SunPower Corporation Common Stock
SPWR
| $3.32M | ﹤0.01% |
146,565
-9,667
| -6% | -$226K |
|
|
VSTO
1843
DELISTED
Vista Outdoor Inc.
VSTO
| $3.32M | ﹤0.01% |
82,311
-2,890
| -3% | -$119K |
|
|
INBX
1844
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $3.32M | ﹤0.01% |
99,602
+75,626
| +315% | +$2.3M |
|
1845
Beyond Meat
BYND
$279M
| $3.31M | ﹤0.01% |
31,440
+550
| +2% | +$67.3K |
|
|
HSKA
1846
DELISTED
Heska Corp
HSKA
| $3.3M | ﹤0.01% |
12,779
-460
| -3% | -$117K |
|
1847
Suzano
SUZ
$10.3B
| $3.3M | ﹤0.01% |
+330,311
| New | +$3.63M |
|
1848
Middlesex Water
MSEX
$1.08B
| $3.3M | ﹤0.01% |
32,080
+303
| +1% | +$31.1K |
|
1849
Cenovus Energy
CVE
$53.8B
| $3.29M | ﹤0.01% |
327,181
+183,514
| +128% | +$1.57M |
|
1850
TriplePoint Venture Growth BDC
TPVG
$185M
| $3.28M | ﹤0.01% |
207,114
-6,325
| -3% | -$99K |
|
Similar funds
AllianceBernstein's Q3 2021 Portfolio in Review
As of Q3 2021, AllianceBernstein held 3,430 positions worth $253B, up 1.8% from $249B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AllianceBernstein's Q3 2021 filing shows 114 new, 1,102 increased, 1,623 reduced and 152 closed positions. Its largest new stake was Freshworks: 2,094,708 shares worth $89.4M. The largest sale was Alphabet (Google) Class C, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q3 2021 buy was Freshworks: 2,094,708 shares worth $89.4M.
- AllianceBernstein added most to Qualcomm in Q3 2021, an estimated $621M increase.
- AllianceBernstein's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $693M.
- AllianceBernstein fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $230M.
- AllianceBernstein's ten largest holdings make up 25% of its $253B portfolio in Q3 2021.
- AllianceBernstein opened 114 new positions and closed 152 in Q3 2021.
- AllianceBernstein's portfolio value rose 1.8% quarter-over-quarter to $253B.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.